MATAWAN, N.J. & EUGENE, Ore.--(BUSINESS WIRE)-- Apimeds Pharmaceuticals US, Inc. (APUS) (“Apimeds”) today announced the expansion of the Apimeds ai ² Futures Lab program through a new collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback